| Section |
Status |
CCG |
Name |
| 10.01.03 |
Formulary
|
 |
Abatacept injection |
| 01.05.03 |
Formulary
|
|
Adalimumab injection IBD |
| 10.01.03 |
Formulary
|
|
Adalimumab injection rheumatology indications |
| 02.12 |
Restricted Use
|
|
Alirocumab injection |
| 01.02 |
Restricted Use
|
|
Aprepitant caps, oral suspension gastroparesis - off-label |
| 09.01.04 |
Formulary
|
|
Avatrombopag tabs |
| 10.01.03 |
Formulary
|
|
Baricitinib tabs |
| 01.02 |
Formulary
|
|
Botulinum toxin A Xeomin® - chronic sialorrhoea |
| 01.02 |
Restricted Use
|
|
Botulinum toxin A Xeomin® - gastroenterology endoscopic indications off-label |
| 01.07.04 |
Restricted Use
|
|
Botulinum toxin A Xeomin® - anal-fissures - off-label |
| 12.04 |
Restricted Use
|
|
Botulinum toxin type A Xeomin® - Spasmodic dysphonia - off-label |
| 10.01.03 |
Formulary
|
|
Certolizumab pegol injection musculoskeletal conditions |
| 09.05.01.02 |
Restricted Use
|
|
Cinacalcet tablets secondary hyperparathyroidism in ESRD |
| 05.01.07 |
Formulary
|
|
Colistimethate sodium powder for solution for injection or inhalation - Colomycin® brand Pseudomonas lung infection in non-CF bronchiectasis - off-label |
| 02.01.01 |
Formulary
|
|
Digoxin specific antibody fragments |
| 09.01.04 |
Restricted Use
|
|
Eltrombopag tablets |
| 09.01.04 |
Restricted Use
|
|
Eltrombopag tablets |
| 10.01.03 |
Formulary
|
|
Etanercept injection rheumatology indications |
| 02.12 |
Restricted Use
|
|
Evolocumab injection |
| 04.07.04.02 |
Formulary
|
|
Fremanezumab subcutaneous injection |
| 04.07.04.02 |
Formulary
|
|
Galcanezumab subcutaneous injection |
| 01.05.03 |
Formulary
|
|
Golimumab injection ulcerative colitis |
| 10.01.03 |
Formulary
|
|
Golimumab injection rheumatology indications |
| 02.11 |
Formulary
|
|
Idarucizumab infusion |
| 01.05.03 |
Formulary
|
|
Infliximab injection cancer immunotherapy related colitis - off-label |
| 01.05.03 |
Formulary
|
|
Infliximab injection IBD |
| 10.01.03 |
Formulary
|
|
Infliximab injection licensed rheumatology indications |
| 09.01.04 |
Formulary
|
|
Lusutrombopag tabs |
| 08.03.04.03 |
Formulary
|
|
Octreotide injection off-label uses |
| 08.02.03 |
Restricted Use
|
|
Rituximab injection TTP - off-label |
| 09.01.04 |
Formulary
|
|
Rituximab injection immune thrombocytopenia - off-label |
| 10.01.03 |
Formulary
|
|
Rituximab injection rheumatology - licensed indications |
| 09.01.04 |
Restricted Use
|
|
Romiplostim injection |
| 10.01.03 |
Formulary
|
|
Sarilumab pre-filled pen or syringe |
| 10.01.03 |
Formulary
|
|
Secukinumab injection ankylosing spondylitis & psoriatic arthritis |
| 06.06.01 |
Formulary
|
|
Teriparatide injection use in women |
| 10.01.03 |
Formulary
|
|
Tocilizumab injection arthritis |
| 01.05.03 |
Formulary
|
|
Tofacitinib tabs gastroenterology indications |
| 10.01.03 |
Formulary
|
|
Tofacitinib tabs rheumatology indications |
| 10.01.03 |
Formulary
|
|
Upadacitinib prolonged release tablets |
| 01.05.03 |
Formulary
|
|
Ustekinumab injection gastrointestinal indications |
| 10.01.03 |
Formulary
|
|
Ustekinumab injection psoriatic arthritis |
| 01.05.03 |
Formulary
|
|
Vedolizumab injection |
